Atrial Fibrillation Surgery Market Overview
The Atrial Fibrillation Surgery Market size is estimated to reach $3.7 billion by 2026, growing at a CAGR of 10.7% during the forecast period 2021-2026. Atrial Fibrillation Surgery is a procedure to treat atrial fibrillation and atrial flutter. Atrial fibrillation is an abnormal heart rhythm caused by the irregular beating of the atrial chamber. Symptoms of the condition include palpitations, shortness of breath, chest pain, and fainting. If left untreated, atrial fibrillations can result in stroke or heart failure. Atrial fibrillation can be treated or managed through non-surgical procedures such as beta-blocker medications and electric cardioversion as well as surgical procedures like Catheter Ablation and Surgical Ablation. The global increase in the prevalence of risk factors such as obesity, tobacco usage, and blood pressure is projected to increase demand for Atrial Fibrillation Surgeries during the forecast period. However, the lack of skilled surgeons to perform such surgeries in low-income countries is a major challenge to the Atrial Fibrillation Surgery Industry.
The report: “Atrial Fibrillation Surgery Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Atrial Fibrillation Surgery Market.
By End User: Hospitals, Surgical Centers, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (the Middle East and Africa).
- Geographically, North America accounted for the largest Atrial Fibrillation Surgery market share in 2020 owing to the increasing occurrence of atrial fibrillation in the region and high patient awareness levels.
- A higher success rate of the surgical procedure when compared to medications in preventing Atrial Fibrillation is anticipated to drive the market. However, the low awareness levels regarding the symptoms and risks of Atrial Fibrillation in developing regions are anticipated to hamper growth opportunities.
- Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Atrial Fibrillation Surgery Market Report.
Atrial Fibrillation Surgery Market Segment, By Geography, 2020 (%)
For more details on this report - Request for Sample
Atrial Fibrillation Surgery Market Segment Analysis-By Surgery Type
Based on Surgery Type, the Atrial Fibrillation Surgery Market is segmented into Catheter Ablation, Maze Procedure, Minimaze Procedure, and AV Node Ablation. The Catheter ablation segment is anticipated to have the largest share of the market in 2020 and is poised to dominate the market during the forecast period 2021-2026. This is attributed to the relatively lower surgical costs, favorable reimbursement policies, and the minimal invasiveness of the surgical procedure. Patients can be usually discharged after an overnight observation following the completion of Catheter Ablation. The Minimaze Procedure is anticipated to register significant growth during the forecast period at a CAGR of 12.1%. Minimaze procedure is similar to the Maze procedure but with fewer atrial incisions in order to decrease complexity and risk of complications. The rapid growth of this segment is owing to their low invasiveness and relatively high success rate of around 67-91%.
Atrial Fibrillation Surgery Market Segment Analysis-By End User
The Atrial Fibrillation Surgery Market based on End User can be further segmented into Hospitals, Surgical Centers, and Others. The Surgical Centre segment accounted for the largest share of the market in 2020 and is also anticipated to witness the fastest growth at a CAGR of 11.6% during the forecast period 2021-2026. The rapid growth can be attributed to factors such as the minimal invasiveness of surgical procedures and the spread of the Covid-19 pandemic. Surgical procedures such as Catheter Ablation and Minimaze are minimally invasive. This reduces the time required for the surgery and limits the need for long observation time post-surgery. Usually, patients can be discharged on the same day or after overnight observation. This allows these procedures to be carried out in Surgical Centers without difficulty. Moreover, the rapid influx of Covid-19 patients in hospitals has increased the risk of virus transmission. This has further boosted the growth of surgical centers.
Atrial Fibrillation Surgery Market Segment Analysis-By Geography
The Atrial Fibrillation Surgery Market based on Geography can be segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. The North American segment is projected to dominate the Atrial Fibrillation Surgery market during the forecast period 2021-2026 with a market share of 33% owing to the high prevalence of patients suffering from atrial fibrillation in the region. For instance, the number of patients with atrial fibrillation in the US was estimated to be between 2.7 million and 6.1 million in 2020 and this is projected to become 12.1 million by 2030. The highly developed healthcare infrastructure and favorable reimbursement policies in the region are the other factors driving the segment’s growth. The Asia Pacific region is predicted to grow the fastest owing to the increase in awareness, the surge in public healthcare spending, and rapid growth in the prevalence of lifestyle diseases such as obesity, diabetes, and high blood pressure.
Atrial Fibrillation Surgery Market Drivers
- Increase in Geriatric Population is Projected to Drive Market Growth.
There were around 727 million persons over the age of 65 in 2020 and constituted 9.3% of the overall population. The geriatric population is predicted to reach 16% by 2050. This is anticipated to drive the market during the forecast period as the geriatric population is more susceptible to develop atrial fibrillation. According to the Centres for Disease Control (CDC), only around 2% of the population under 65 have atrial fibrillation in the US, while for those above 65 years of age, the prevalence increases to 9%.
- Rise in Sedentary Lifestyle is Anticipated to Boost Demand.
Owing to the growth in global disposable income and urbanization, more people are following a sedentary lifestyle. This is causing an increase in lifestyle diseases such as obesity, high blood pressure, and diabetes. Around 39% of the global adult population is overweight and 9.8% suffer from diabetes. Furthermore, 26% of the population suffers from hypertension and this is projected to reach 29% by 2025. Such diseases increase the risk factors associated with atrial fibrillation. Moreover, the use of tobacco and alcohol also significantly increases the risk. For instance, the rate of atrial fibrillation in smokers is 1.4 times higher than that of non-smokers.
Atrial Fibrillation Surgery Market Challenges
- The Increased Risk Associated with Surgical Procedures is Anticipated to Hamper Market Growth.
Atrial Fibrillation Surgery poses certain risks to the patient which may impact growth as the patient may prefer non-surgical treatment options. Some of the major risks include blood vessel damage, heart valve damage, new or worsening fibrillation, blood clots, stroke, and slow heart rate that may require a pacemaker to fix. Moreover, the success rate of the surgery is around 70-75% and may require multiple surgeries to treat the condition. This can further increase the chances of complications happening.
- Lack of Trained Professionals to Perform Surgical Procedures is Projected to Limit Growth Opportunities
The lack of professional and experienced cardiology surgeons capable of performing such surgical procedures in some developing and under-developed regions is anticipated to limit growth. Even though the occurrence of atrial fibrillations is increasing, the low public and private investments in the healthcare sector have caused an increase in the gap between the number of doctors and patients. For instance, the doctor-to-patient ratio in Kenya is 1:16,000 while it is 1:40,000 in Nigeria. The minimum recommended ratio according to WHO is 1:1000.
Atrial Fibrillation Surgery Market Industry Outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Atrial Fibrillation Surgery Market. The top 10 companies of the industry include:
- Boston Scientific Corporation
- Medtronic Plc.
- ArtiCure Inc.
- Cardiofocus Inc.
- Biosense Webster
- St. Jude Medical
- Boehringer Ingelheim GmbH
- Johnsons Johnsons Ltd.
- Cardima Inc.
- In June 2021, Medtronic announced it received US Food and Drug Administration (FDA) approval for the Arctic Front Family of Cardiac Cryoablation Catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation.
- In June 2020, Boston Scientific Corporation announced the US launch of the DIRECT Technology, a tool for the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures.
Report Code: HCR 0714
Report Code: HCR 0017
For more Lifesciences and Healthcare Market related reports, please click here